United Therapeutics Statistics
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
537.80-7.21 (-1.32%)
Market open · Delayed 15 min · as of Oct 8, 9:45 AM ET
United Therapeutics by the numbers
United Therapeutics has a market capitalization of $23.07 billion based on 42.89M shares outstanding. Its trailing P/E ratio is 19.3, above the 5-company peer median of 17.4, and its forward P/E is 17.2. The stock trades 5.0% above its 50-day average and 2.3% above its 200-day average.
Average daily trading volume is 655.10K shares, or about $352.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
UTHR valuation vs. peer median
| Metric | UTHR | Peer median | Difference |
|---|---|---|---|
| Market cap | $23.07B | $21.60B | +7% |
| P/E (TTM) | 19.3 | 17.4 | +11% |
| Forward P/E | 17.2 | 17.8 | -3% |
| Avg. volume | 655.10K | 2.68M | -76% |
Peer median across 8 companies: GMAB, ROIV, INSM, VTRS, ZTS, ALNY, ASND, JAZZ.
Valuation
- Market cap
- $23.07B
- P/E (TTM)
- 19.26
- Forward P/E
- 17.20
- Price / sales (latest FY)
- 7.25
- EPS (TTM)
- $27.92
- Shares outstanding
- 42.89M
Price and trading
- Previous close
- 545.00
- Open
- 545.00
- Day range
- 535.35 – 545.00
- 52-week range
- 409.07 – 609.35
- 52-week change
- +19.30%
- 50-day moving average
- 511.97
- 200-day moving average
- 525.86
- Beta
- —
- Volume
- 22.25K
- Average volume
- 655.10K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 23.07B
- Pe
- 19.26
- Forward Pe
- 17.20
- Eps
- 27.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 609.35
- Week52 Low
- 409.07
- Avg Volume
- 655.10K
- Shares Outstanding
- 42.89M
- Ma50
- 511.97
- Ma200
- 525.86
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -11.74%
- Pct From52w Low
- 31.47%